Funder: National Institutes of Health

Due Dates: February 5, 2025 (New) | March 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | October 5, 2026 (New) | November 5, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $500,000 direct costs per year, for a maximum project period of 5 years.

Summary: Supports academic-industrial partnerships to translate and validate in vivo imaging, data science, or spectroscopic technologies for cancer research and care.

Key Information: Applications must include at least one academic and one industrial partner; commercial production and basic research are not supported.